MedTrace Logo

Technology Enhanced Behavioral Activation Treatment for Substance Use

NCT02707887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2023-10-16

No results posted yet for this study

Summary

The purpose of this study is to:

1. test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use
2. use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.

Conditions

  • Substance-Related Disorders
  • Depressive Disorder
  • Behavioral Symptoms
  • Risk-Taking
  • Sexual Behavior

Interventions

BEHAVIORAL

LETS ACT

The Life Enhancement Treatment for Substance Use (LETS ACT)

BEHAVIORAL

LETS ACT-SE

Participants assigned to the smartphone-enhanced LETS ACT (LETS ACT-SE) condition will be provided the exact same treatment as outlined in LETS ACT, except that LETS ACT-SE participants will record their daily goals using smartphone technology.

BEHAVIORAL

Treatment as Usual

Participants will receive the treatment typically provided to patients at the substance use treatment facility.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Stacey Daughters, Ph.D. · University of North Carolina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02707887 on ClinicalTrials.gov